Affiliate & Vendor Disclosure
Semaglutide for Women (semaglutideforwomen.com) is committed to transparency about how this site is funded and how our content is influenced — or more accurately, how it isn’t.
Our primary telehealth partner is Delilah, a licensed telehealth platform that connects patients with GLP-1 prescribers. When you sign up through our referral link, we earn a commission. This relationship does not influence our editorial content or vendor evaluations.
Telehealth Affiliate Relationships
This site may earn commissions when readers sign up for services through our telehealth partner links. These are licensed medical providers offering legitimate prescriptions for FDA-approved medications. We only partner with telehealth services we believe provide genuine value to our readers.
Affiliate relationships do not influence our editorial content, our analysis of clinical data, or our recommendations. Our pro-prescription editorial position predates any affiliate relationship and reflects our genuine assessment of the safest path to GLP-1 therapy.
Research Peptide Vendors
We do NOT receive compensation from any research peptide vendor. Our vendor comparison page exists as an editorial resource for readers researching the market landscape. Vendor listings are based on publicly available information and independent analysis. No vendor has paid for inclusion, placement, or favorable coverage.
What We Do Not Do
- We do not accept payment from research peptide vendors for reviews or listings
- We do not sell or distribute any peptides, medications, or supplements
- We do not provide medical advice or prescriptions
- We do not allow sponsors or advertisers to influence our scientific analysis
- We do not recommend research peptides for human consumption
FTC Compliance
This disclosure is provided in accordance with the Federal Trade Commission’s guidelines on endorsements and testimonials (16 CFR Part 255). We believe in full transparency about our financial relationships and editorial independence.
Questions about our disclosure policies can be directed to the site contact form.
Last updated: February 2026